People

Services

Industries

Firm

About

Knowledge

Careers

News

Events

Contact

Connect

Privacy Policy

Disclaimer

Terms of Use

Accessibility

Payments

Legal

Calgary

Toronto

Edmonton

Ottawa

Vancouver

New York

Montréal

Sarah E. Gilbert

Environmental Lawyer | Health & Safety

Partner

Julia E. Schatz

Commercial & Regulatory Lawyer | Environmental & Agribusiness

Partner 

Gatlin Smeijers

Environmental Lawyer at Bennett Jones Toronto

On December 31, 2025, the Federal Government published the Prohibition of Certain Toxic Substances Regulations, 2025 under the Canadian Environmental Protection Act, 1999. When they come into effect on June 30, 2026, the 2025 Regulations will repeal and replace the Prohibition of Certain Toxic Substances Regulations, 2012. The Federal Government published a proposed version of the 2025 Regulations in 2022 for public consultation.

Federal Government Publishes Prohibition of Certain Toxic Substances Regulations

Federal Government Publishes Prohibition of Certain Toxic Substances Regulations, 2025

On June 5, 2025, the Competition Bureau (the Bureau) published its <a rel="noopener noreferrer" href="https://competition-bureau.canada.ca/en/how-we-foster-competition/education-and-outreach/publications/environmental-claims-and-competition-act#sec02-2" target="_blank">final Guidelines for environmental claims</a> under the Competition Act (the Act). The Guidelines were created to help businesses and the public understand the Bureau's approach to deceptive marketing provisions under the Act as they relate to environmental claims, including with respect to the new environment-specific provisions that were enacted in 2024. While not binding on the Commissioner of Competition nor the Competition Tribunal, the Guidelines provide visibility into the Bureau's interpretation and approach to environmental claims.

Final Guidelines From the Competition Bureau on Environmental Claims in Canada

Final Guidelines from the Competition Bureau on Environmental Claims in Canada

Samantha Chenatte

Associate at Bennett Jones Vancouver

Associate

On March 7, 2025, Health Canada’s Pest Management Regulatory Agency (PMRA) published two consultation documents as part of its ongoing work to clarify which categories of pest control products are subject to the Pest Control Products Act (PCPA) and the Pest Control Products Regulations (PCPR) passed under it, which products are exempt and which may be authorized (without registration being required). The PMRA is seeking further stakeholder input on the amendments being proposed. The comment period is open until May 6, 2025.

Pest Management Regulatory Agency Opens Pre Consultation Period on Proposed Changes

Pest Management Regulatory Agency Opens Pre-Consultation Period on Proposed Changes to the Pest Control Products Regulations

The Government of Canada published the final "State of per- and polyfluoroalkyl substances (PFAS) report" (<a rel="noopener noreferrer" href="https://www.canada.ca/en/environment-climate-change/services/evaluating-existing-substances/state-per-polyfluoroalkyl-substances-report.html" target="_blank">State of PFAS Report</a>), the "Risk management approach for per- and polyfluoroalkyl substances (PFAS), excluding fluoropolymers" (<a rel="noopener noreferrer" href="https://www.canada.ca/en/environment-climate-change/services/evaluating-existing-substances/risk-management-approach-per-polyfluoroalkyl-substances.html" target="_blank">Risk Management Approach</a>) and a proposed Order adding a toxic substance to Part 2 of Schedule 1 of the Canadian Environmental Protection Act, 1999 (CEPA) (<a rel="noopener noreferrer" href="https://canadagazette.gc.ca/rp-pr/p1/2025/2025-03-08/html/reg2-eng.html" target="_blank">Proposed Order</a>) in the Canada Gazette on March 8, 2025.  These documents are open for public consultation until May 7, 2025.

Federal Government publishes State of PFAS Report and Risk Management Approach

Federal Government Publishes State of PFAS Report and Risk Management Approach

Gary S.A. Solway

Technology, Media & Corporate Lawyer | Governance

Matthew Flynn

Technology Transaction Lawyer at Bennett Jones Toronto

Artificial intelligence has entered a new phase: models can take actions&mdash;deploy code, interact with enterprise systems and operate through automated agents&mdash;with real-world consequences. AI is no longer just a technical capability; it is a core governance priority.

Boards Must Oversee AI Risk

Stop Hallucinating - Boards Must Oversee AI Risk

Christine A. Viney

Commercial Litigation Lawyer at Bennett Jones Calgary

Kristos J. Iatridis

Corporate & Private Equity Lawyer | Oil Sands Projects

Captive insurance is gaining traction as organizations look for smarter, more resilient ways to finance risk. This overview explores how Alberta captives work, their benefits, and whether they may be a fit for your business.

Curious about Captives Youre Not Alone

Curious about Captives? You're Not Alone!

Christopher J. Doucet

Corporate & Mining Lawyer | M&A & Corporate Finance

Doug Fenton

Litigation Lawyer at Bennett Jones Toronto

Kanwar Brar

Commercial Litigation Lawyer at Bennett Jones Toronto

In a recent enforcement decision, CIRO imposed substantial sanctions on a securities dealer and its Ultimate Designated Person (UDP) for improper trading practices and significant compliance failures. The case underscores CIRO&rsquo;s strict approach to &ldquo;tone from the top,&rdquo; particularly where senior executives fail to uphold or promote firm-wide compliance standards. It also highlights that sanctions are assessed independently of liability findings and can include severe financial penalties, bans, and ongoing regulatory oversight of governance structures.

CIRO Issues Stiff Penalties for Dealer Conduct

Benjamin K. Reingold

Intellectual Property Litigation Lawyer at Bennett Jones Calgary

Melissa M. Dimilta

Intellectual Property Lawyer at Bennett Jones Toronto

Partner, Trademark Agent

Lorelei Graham

IP Lawyer | Food & Agribusiness

This blog examines why Canada&rsquo;s Federal Court is the preferred venue for pharmaceutical patent litigation. It highlights its specialized expertise, efficient procedures and consistent, precedent-driven decisions.

Northern Advantage Canadas Federal Court as a Venue for Pharmaceutical Patent Litigation

Northern Advantage: Canada's Federal Court as a Venue for Pharmaceutical Patent Litigation

Ahmed Elmallah

Intellectual Property Lawyer at Bennett Jones Edmonton

Counsel, Patent Agent, Trademark Agent

This four-part AI Insights Quick Read series explores how routine generative AI use can expose confidential information, weaken privilege and erode intellectual property value. Using US v. Heppner as a starting point, it examines disclosure risk, shadow AI, content dilution and key implications for Canadian organizations.

Case Comment: St. Lawrence Cement v. Barrette

From the Same Authors